Treatment options for patients who develop brain metastases secondary to non-small-cell
lung cancer have rapidly expanded in recent years. As a key adjunct to surgical and …

Lung cancer is characterized by the highest incidence of solid tumor-related brain
metastases, which are reported with a growing incidence during the last decade. Prognostic …

Abstract Purpose of Review To summarize current approaches in the management of brain
metastases from non-small cell lung cancer (NSCLC). Recent Findings Local treatment has …

Introduction: Central nervous system (CNS) metastases represent an important cause of
morbidity and mortality in non-small cell lung cancer (NSCLC) patients. Local approaches of …

ABSTRACT Introduction: Brain metastases (BMs) develop in up to 40% of patients with non-
small cell lung cancer (NSCLC). In many recent practice-changing clinical trials, patients …

Non-small-cell lung cancer (NSCLC) brain metastases are common. Even though there are
various subsets of NSCLC with molecular alterations, there is a common theme of brain …

BACKGROUND. For patients with stage IV nonsmall cell lung cancer (NSCLC) who present
with brain metastasis (BMs), standard platinum‐based chemotherapy regimens have …

Multimodality management of non-small cell lung cancer patie... : Current Opinion in
Oncology Multimodality management of non-small cell lung cancer patients with brain …

Background Chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitors are controversial in the treatment of patients with brain metastases from non-small …

Brain metastases are common in patients with non-small-cell lung cancer (NSCLC).
Because of associated poor prognosis and limited specific treatment options, there is a real …